{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T02:14:27Z","timestamp":1648520067058},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s10354-006-0276-7","type":"journal-article","created":{"date-parts":[[2006,12,7]],"date-time":"2006-12-07T17:10:25Z","timestamp":1165511425000},"page":"587-595","source":"Crossref","is-referenced-by-count":2,"title":["Psoriasis Arthritis"],"prefix":"10.1007","volume":"156","author":[{"given":"Edmund","family":"Cauza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Dunky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"5","key":"276_CR1","first-page":"1247","volume":"27","author":"M Shbeeb","year":"2000","unstructured":"Shbeeb M, Uramoto KM, Gibson LE, O'Fallon WM, Gabriel SE (2000)The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982\u20131991. J Rheumatol 27(5): 1247\u20131250","journal-title":"J Rheumatol"},{"issue":"8","key":"276_CR2","first-page":"511","volume":"53","author":"DG Leonard","year":"1978","unstructured":"Leonard DG, O'Duffy JD, Rogers RS (1978) Prospective analysis of psoriatic arthritis in patients hospitalized for psoriasis. Mayo Clin Proc 53(8): 511\u2013518","journal-title":"Mayo Clin Proc"},{"key":"276_CR3","volume-title":"Oxford Textbook of Rheumatology","author":"D Gladman","year":"2004","unstructured":"Gladman D (2004) Psoriatic Arthritis. In Isenberg DA, et al (eds). Oxford Textbook of Rheumatology, 3rd edition. UK Oxford University Press, Oxford","edition":"3"},{"issue":"7","key":"276_CR4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.1780360705","volume":"36","author":"D Veale","year":"1993","unstructured":"Veale D, Yanni G, Rogers S, Barnes L, Bresnihan B, Fitzgerald O (1993) Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis. Arthritis Rheum 36(7): 893\u2013900","journal-title":"Arthritis Rheum"},{"issue":"7","key":"276_CR5","first-page":"1115","volume":"19","author":"D Buskila","year":"1992","unstructured":"Buskila D, Langevitz P, Gladman DD, Urowitz S, Smythe HA (1992) Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Rheumatol 19(7): 1115\u20131119","journal-title":"J Rheumatol"},{"issue":"238","key":"276_CR6","first-page":"127","volume":"62","author":"DD Gladman","year":"1987","unstructured":"Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK (1987) Psoriatic arthritis (PSA) \u2013 an analysis of 220 patients. Q J Med 62(238): 127\u2013141","journal-title":"Q J Med"},{"issue":"5","key":"276_CR7","first-page":"1041","volume":"28","author":"P Rahman","year":"2001","unstructured":"Rahman P, Nguyen E, Cheung C, Schentag CT, Gladman DD (2001) Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol 28(5): 1041\u20131044","journal-title":"J Rheumatol"},{"key":"276_CR8","doi-asserted-by":"crossref","unstructured":"Bowcock AM, Cookson WO (2004) The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 Spec No 1: R43\u2013R55","DOI":"10.1093\/hmg\/ddh094"},{"issue":"32","key":"276_CR9","first-page":"181","volume":"1973","author":"JM Moll","year":"2001","unstructured":"Moll JM, Wright V (2001) Familial occurrence of psoriatic arthritis. Ann Rheum Dis 1973(32): 181\u2013201","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"276_CR10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00002281-200107000-00005","volume":"13","author":"T Hohler","year":"2002","unstructured":"Hohler T, Marker-Hermann E (2002) Psoriatic arthritis: clinical aspects, genetics, and the role of T cells. Curr Opin Rheumatol 13(4): 273\u2013279","journal-title":"Curr Opin Rheumatol"},{"key":"276_CR11","first-page":"3","volume":"28","author":"AC Barton","year":"2001","unstructured":"Barton AC, Bruce IN, Silman AJ (2001) Genetic studies of psoriatic arthritis:dissecting joints and skin. J Rheumatol 28: 3\u20135","journal-title":"J Rheumatol"},{"key":"276_CR12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-2249.2000.01140.x","volume":"119","author":"GK Tay","year":"2000","unstructured":"Tay GK, Hui J, Gaudieri S et al (2000) PERB11(MIC): a polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis. Clin Exp Immunol 119: 553\u2013558","journal-title":"Clin Exp Immunol"},{"key":"276_CR13","doi-asserted-by":"crossref","first-page":"12445","DOI":"10.1073\/pnas.93.22.12445","volume":"93","author":"V Groh","year":"1996","unstructured":"Groh V, Braham S, Bauer S, Hermann A, Beauchamp M, Spies T (1996) Cell stress regulated human MHC class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci USA 93: 12445\u201312450","journal-title":"Proc Natl Acad Sci USA"},{"key":"276_CR14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","volume":"285","author":"S Bauer","year":"1999","unstructured":"Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727\u2013729","journal-title":"Science"},{"issue":"5","key":"276_CR15","first-page":"973","volume":"29","author":"S Gonzalez","year":"2002","unstructured":"Gonzalez S, Martinez-Borra J, Lopez-Vazquez A, Garcia-Fernandez S, Torre-Alonso JC, Lopez-Larrea C (2002) MICA rather than MICB, TNFA, or HLA-DRB1 is associated with susceptibility to psoriatic arthritis. J Rheumatol 29(5): 973\u2013978","journal-title":"J Rheumatol"},{"issue":"5","key":"276_CR16","first-page":"304","volume":"6","author":"J Karvonen","year":"1974","unstructured":"Karvonen J, Lassus A, Sievers U, Tiilikainen A (1974) HLAantigens in psoriatic arthritis. Ann Clin Res 6(5): 304\u2013307","journal-title":"Ann Clin Res"},{"key":"276_CR17","unstructured":"McKendry RJ, Sengar DP, DesGroseilliers JP, Dunne JV (1984) Frequency of HLA antigens in patients with psoriasis or psoriatic arthritis. Can Med Assoc J 15, 130(4): 411\u2013415"},{"key":"276_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2230.2001.00792.x","volume":"26","author":"U Fearon","year":"2001","unstructured":"Fearon U, Veale D (2001) Pathogenesis of psoriatic arthritis. Clin Exp Dermatol 26: 333\u2013337","journal-title":"Clin Exp Dermatol"},{"key":"276_CR19","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.4049\/jimmunol.166.4.2878","volume":"166","author":"PJ Costello","year":"2001","unstructured":"Costello PJ, Winchester RJ, Curran SA, Peterson KS, Kane DJ, Bresnihan B (2001) Psoriatic arthritis joint fluids are characterized by CD8 and CD4 T cell clonal expansions appear antigen driven. J Immunol 166: 2878\u20132886","journal-title":"J Immunol"},{"key":"276_CR20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0198-8859(99)00034-8","volume":"60","author":"I Tassiulas","year":"1999","unstructured":"Tassiulas I, Duncan SR, Centola M, Theofilopoulos AN, Boumpas DT (1999) Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis. Human Immunol 60: 479\u2013491","journal-title":"Human Immunol"},{"key":"276_CR21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jmg.39.10.767","volume":"39","author":"P Weisenseel","year":"2002","unstructured":"Weisenseel P, Laumbacher B, Besgen P, Ludolph-Hauser D, Herzinger T, Roecken M, Wank R, Prinz JC (2002) Streptococcal infection distinguishes different types of psoriasis. Journal of Medical Genetics 39: 767\u2013768","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"276_CR22","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1365-2230.2001.00831.x","volume":"26","author":"JC Prinz","year":"2001","unstructured":"Prinz JC (2001) Psoriasis vulgaris \u2013 a sterile antibacterial skin reaction mediated by cross-reactive T cells? An immunological view of the pathophysiology of psoriasis. Clin Exp Dermatol 26(4): 326\u2013332","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"276_CR23","first-page":"399","volume":"15","author":"K Rantakokko","year":"1997","unstructured":"Rantakokko K, Rimpilainen M, Uksila J, Jansen C, Luukkainen R, Toivanen P (1997) Antibodies to streptococcal cell wall in psoriatic arthritis and cutaneous psoriasis. Clin Exp Rheumatol 15(4): 399\u2013404","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"276_CR24","first-page":"719","volume":"9","author":"FB Vasey","year":"1982","unstructured":"Vasey FB, Deitz C, Fenske NA, Germain BF, Espinoza LR (1982) Possible involvement of group A streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol 9(5): 719\u2013722","journal-title":"J Rheumatol"},{"issue":"10","key":"276_CR25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/1529-0131(199910)42:10<2055::AID-ANR5>3.0.CO;2-A","volume":"42","author":"Q Wang","year":"1999","unstructured":"Wang Q, Vasey FB, Mahfood JP, Valeriano J, Kanik KS, Anderson BE, Bridgeford PH (1999) V2 regions of 16S ribosomal RNA used as a molecular marker for the species identification of streptococci in peripheral blood and synovial fluid from patients with psoriatic arthritis. Arthritis Rheum 42(10): 2055\u20132059","journal-title":"Arthritis Rheum"},{"key":"276_CR26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/1529-0131(200006)43:6<1244::AID-ANR7>3.0.CO;2-2","volume":"43","author":"CL Danning","year":"2000","unstructured":"Danning CL, Illei GG, Hitchon C, Greer MR, Boumpas DT, McInnes IB (2000) Makrophage-derived cytokine and nuclear factor \u03baB p65 expression in synovial membrane and skin of patients with psoriatic arthritis. Arthritis Rheum 43: 1244\u20131256","journal-title":"Arthritis Rheum"},{"key":"276_CR27","first-page":"1544","volume":"25","author":"C Ritchlin","year":"1998","unstructured":"Ritchlin C, Haas-Smith SA, Hicks D, Cappuccio J, Osterland CK, Looney RJ (1998) Patterns of cytokine production in psoriatic synovium. J Rhematol 25: 1544\u20131552","journal-title":"J Rhematol"},{"key":"276_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0923-1811(99)00031-6","volume":"21","author":"A Nishibu","year":"1999","unstructured":"Nishibu A, Han GW, Iwatsuki K, Matsui T, Inoue M, Akiba H, Kaneko F (1999) Overexpression of monocytederived cytokines in active psoriasis: a relation to coexistent arthropathy. J Dermatol Sci 21: 63\u201370","journal-title":"J Dermatol Sci"},{"key":"276_CR29","first-page":"518","volume":"24","author":"G Partsch","year":"1997","unstructured":"Partsch G, Steiner G, Leeb BF, Dunky A, Br\u00f6ll H, Smolen JS (1997) Highly increased levels of tumor necrosis factor and other proinflammatory cytokines in psoriatic arthritis synovial fluid. J Rhematol 24: 518\u2013523","journal-title":"J Rhematol"},{"key":"276_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s002960050111","volume":"19","author":"O Elkayam","year":"2000","unstructured":"Elkayam O, Yaro I, Shirazi I, Yaron M, Caspi D (2000) Serum levels of IL-10, IL-6, IL-1ra and sIL-2R in patients with psoriatic arthritis. Rheumatol Int 19: 101\u2013105","journal-title":"Rheumatol Int"},{"key":"276_CR31","first-page":"105","volume":"25","author":"G Partsch","year":"1998","unstructured":"Partsch G, Wagner E, Leeb BF, Dunky A, Steiner G, Smolen J (1998) Upregulation of cytokine receptors TNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid. J Rheumatol 25: 105\u2013110","journal-title":"J Rheumatol"},{"issue":"3","key":"276_CR32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1006\/clin.1997.4440","volume":"85","author":"A Dunky","year":"1997","unstructured":"Dunky A, Neumuller J, Menzel J (1997) Interactions of lymphocytes from patients with psoriatic arthritis or healthy controls and cultured endothelial cells. Clin Immunol Immunopathol 85(3): 297\u2013314","journal-title":"Clin Immunol Immunopathol"},{"key":"276_CR33","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3949\/ccjm.66.6.367","volume":"66","author":"LW Moreland","year":"1999","unstructured":"Moreland LW (1999) Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis. Cleve Clin J Med 66: 367\u2013374","journal-title":"Cleve Clin J Med"},{"key":"276_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0149-2918(00)88269-7","volume":"21","author":"MM Goldenberg","year":"1999","unstructured":"Goldenberg MM (1999) Etanercept: anovel drug for the treatment of patients with severe, active rheumatoid arthritis. Clin Ther 21: 75\u201387","journal-title":"Clin Ther"},{"issue":"S57","key":"276_CR35","first-page":"22","volume":"26","author":"EC Keystone","year":"1999","unstructured":"Keystone EC (1999) The role of tumor necrosis factor antagonism in clinical practice. J Rhematol 26(S57): 22\u201328","journal-title":"J Rhematol"},{"key":"276_CR36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2230.1994.tb02687.x","volume":"19","author":"C Bonifati","year":"1994","unstructured":"Bonifati C, Carducci M, Cordiali Fei P, Tento E, Sacerdoti G, Fazio M (1994) Correlated increase of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients-relationships with disease severity. Clin Exp Dermatol 19: 383\u2013387","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"276_CR37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","volume":"3","author":"JM Moll","year":"1973","unstructured":"Moll JM, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3(1): 55\u201378","journal-title":"Semin Arthritis Rheum"},{"key":"276_CR38","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9629(15)40413-6","volume":"316","author":"DD Gladman","year":"1998","unstructured":"Gladman DD (1998) Clinical aspects of the spondylarthropathies. Am J Med Sci 316: 234\u2013238","journal-title":"Am J Med Sci"},{"key":"276_CR39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.1964.03070100037007","volume":"189","author":"RL Black","year":"1964","unstructured":"Black RL, O'Brien WM, Vanscott EJ, Auerbach R, Eisen AZ, Bunim JJ (1964) Methotrexate therapy in psoriatic arthritis; double blind study on 21 patients. Jama 189: 743\u2013747","journal-title":"Jama"},{"issue":"4","key":"276_CR40","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/art.1780270403","volume":"27","author":"RF Willkens","year":"1984","unstructured":"Willkens RF, Williams HJ, Ward JR, Egger MJ, Reading JC, Clements PJ (1984) Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 27(4): 376\u2013381","journal-title":"Arthritis Rheum"},{"key":"276_CR41","unstructured":"Jones G, Crotty M, Brooks P (2000) Interventions for psoriatic arthritis. Cochrane Database Syst Rev (3):CD000212"},{"issue":"3","key":"276_CR42","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF02239195","volume":"7","author":"M Farr","year":"1988","unstructured":"Farr M, Kitas GD, Waterhouse L, Jubb R, Felix-Davies D, Bacon P (1988) Treatment of psoriatic arthritis with sulphasalazine: a one year open study. Clin Rheumatol 7(3): 372\u2013377","journal-title":"Clin Rheumatol"},{"issue":"10","key":"276_CR43","first-page":"2274","volume":"28","author":"C Salvarani","year":"2001","unstructured":"Salvarani C, Macchioni P, Olivieri I, Marchesoni A, Cutolo M, Ferraccioli G et al (2001) A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis. J Rheumatol 28(10): 2274\u20132282","journal-title":"J Rheumatol"},{"issue":"5","key":"276_CR44","first-page":"894","volume":"22","author":"AK Gupta","year":"1995","unstructured":"Gupta AK, Grober JS, Hamilton TA, Ellis CN, Siegel MT, Voorhees JJ et al (1995) Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial. J Rheumatol 22(5): 894\u2013898","journal-title":"J Rheumatol"},{"issue":"6","key":"276_CR45","first-page":"609","volume":"15","author":"A Spadaro","year":"1997","unstructured":"Spadaro A, Taccari E, Mohtadi B, Riccieri V, Sensi F, Zoppini A (1997) Life-table analysis of cyclosporin A treatment in psoriatic arthritis: comparison with other disease-modifying antirheumatic drugs. Clin Exp Rheumatol 15(6): 609\u2013614","journal-title":"Clin Exp Rheumatol"},{"key":"276_CR46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/ard.61.10.942","volume":"61","author":"M Cuchacovich","year":"2002","unstructured":"Cuchacovich M, Soto L (2002) Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis. Ann Rheum Dis 61: 942\u2013943","journal-title":"Ann Rheum Dis"},{"key":"276_CR47","first-page":"POS-566","volume":"59","author":"JJ Scali","year":"2000","unstructured":"Scali JJ, Visentini S, Salomon G, Castelli G, Barcena P, Morales E (2000) Treatment of psoriatic arthritis:open prospective study comparing efficacy and safety profile between leflunomide vs methotrexate. Ann Rheum Dis 59: POS-566","journal-title":"Ann Rheum Dis"},{"key":"276_CR48","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.20253","volume":"50","author":"JP Kaltwasser","year":"2004","unstructured":"Kaltwasser JP, Nash P, Gladman D, Mease (2004) Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial. Arthritis Rheum 50: 1939\u20131950","journal-title":"Arthritis Rheum"},{"key":"276_CR49","first-page":"212","volume":"43","author":"C Dechant","year":"2000","unstructured":"Dechant C, Antoni C, Wendler J (2000) One year outcome of patients with severe psoriatic arthritis treated with infliximab. Arthritis Rheum 43: 212","journal-title":"Arthritis Rheum"},{"key":"276_CR50","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/ard.59.6.428","volume":"59","author":"F Van den Bosch","year":"2000","unstructured":"Van den Bosch F, Kruithof E, Beaten D, De Keyser F, Mielants H, Veys EM (2000) Effects of loading dose regimen of three infusions of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. Ann Rheum Dis 59: 428\u2013433","journal-title":"Ann Rheum Dis"},{"key":"276_CR51","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-002-0246-3","volume":"22","author":"E Cauza","year":"2002","unstructured":"Cauza E, Spak M, Cauza K, Hanusch-Enserer U, Dunky A, Wagner E (2002) Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab. Rheumatol Int 22: 227\u2013232","journal-title":"Rheumatol Int"},{"key":"276_CR52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2133.2001.04089.x","volume":"144","author":"AL Ogilvie","year":"2001","unstructured":"Ogilvie AL, Antoni C, Dechant C, Manger B, Kalden JR, Schuler G, Luftl M (2001) Treatment of psoriatic arthritis with anti tumor necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexat. Br J Dermatol 144: 587\u2013589","journal-title":"Br J Dermatol"},{"key":"276_CR53","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1067\/mjd.2000.105948","volume":"42","author":"CJ Oh","year":"2000","unstructured":"Oh CJ, Das KM, Gottlieb AB (2000) Treatment with anti tumor necrosis factor alpha (TNF\u03b1) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J Am Acad Dermatol 42: 829\u2013830","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"276_CR54","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/art.10671","volume":"47","author":"C Antoni","year":"2002","unstructured":"Antoni C, Dechant B, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M et al (2002) Open-label study on infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation. Arthritis Rheum 47(5): 506\u2013512","journal-title":"Arthritis Rheum"},{"key":"276_CR55","unstructured":"Antoni C, Kavanaugh A, Kirkham B (2005) The infliximab multinational psoriatic arthritis controlled trial substantial efficacy on synovitis and psoriatic lesions with or without concomitant DMARD therapy. (Impact): Arthritis Rheum in press"},{"issue":"Suppl 9","key":"276_CR56","first-page":"617","volume":"50","author":"A Kavanaugh","year":"2004","unstructured":"Kavanaugh A, Krueger G, De Vlam K et al (2004) Infliximab significantly improves joint and skin involvement in psoriatic arthritis to a substantial extend and irrespective of baseline joint involvement or MTX use: analysis of clinical response from the Impact 2 trial. Arthritis Rheum 50 (Suppl 9): 617","journal-title":"Arthritis Rheum"},{"key":"276_CR57","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(00)02530-7","volume":"356","author":"PJ Mease","year":"2000","unstructured":"Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ (2000) Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial. Lancet 356: 385\u2013390","journal-title":"Lancet"},{"key":"276_CR58","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.0007-0963.2001.04529.x","volume":"146","author":"S Iyer","year":"2002","unstructured":"Iyer S, Yamauchi P, Lowe NJ (2002) Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy. Br J Dermatol 146: 118\u2013121","journal-title":"Br J Dermatol"},{"key":"276_CR59","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1002\/art.20335","volume":"50","author":"P Mease","year":"2004","unstructured":"Mease P, Gladman DD, Ritchlin C et al (2004) Adalimumab therapy in patients with psoriatic arthritis: 24 week result of a phase III study. Arthritis Rheum 50: 4097","journal-title":"Arthritis Rheum"},{"issue":"11","key":"276_CR60","first-page":"1369","volume":"4","author":"SN Nikas","year":"2003","unstructured":"Nikas SN, Drosos AA (2003) Onercept. Serono. Curr Opin Investig Drugs 4(11): 1369\u20131376","journal-title":"Curr Opin Investig Drugs"},{"key":"276_CR61","doi-asserted-by":"crossref","unstructured":"Papp K, Mease P, Garovoy M et al (2004) Efalizumab in patients with psoriatic arthritis: results of a phase II randomized double-blind placebo controlled study. Presented at International Psoriasis Symposium, Toronto","DOI":"10.1016\/j.jaad.2003.10.550"},{"key":"276_CR62","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.4049\/jimmunol.168.9.4462","volume":"168","author":"AJ Da Silva","year":"2002","unstructured":"Da Silva AJ, Brickelmaier M, Majeau GR, Li Z, Su L, Hsu YM, Hochman PS (2002) Alefacept, an immunomodulatory recombinant LFA-3\/IgG1 fusion protein, induces CD16 signaling and CD2\/CD16-dependent apoptosis of CD2(+) cells. J Immunol 168: 4462\u20134471","journal-title":"J Immunol"},{"key":"276_CR63","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/eji.200323586","volume":"33","author":"JC Cooper","year":"2003","unstructured":"Cooper JC, Morgan G, Harding S, Subramanyam M, Majeau GR, Moulder K, Alexander DR (2003) Alefacept selectively promotes NK cell-mediated deletion of CD45R0+ human T cells. Eur J Immunol 33: 666\u2013675","journal-title":"Eur J Immunol"},{"key":"276_CR64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archderm.139.6.719","volume":"139","author":"M Lebwohl","year":"2003","unstructured":"Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE (2003) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139: 719\u2013727","journal-title":"Arch Dermatol"},{"key":"276_CR65","doi-asserted-by":"crossref","unstructured":"Kremer JM, Westhovens R, Leon M, Di Giorgio E, Alten R, Steinfeld S et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 13, 349(20): 1907\u20131915","DOI":"10.1056\/NEJMoa035075"},{"issue":"4","key":"276_CR66","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.coph.2004.04.003","volume":"4","author":"IB McInnes","year":"2004","unstructured":"McInnes IB, Gracie JA (2004) Interleukin-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 4(4): 392\u2013397","journal-title":"Curr Opin Pharmacol"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0276-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-006-0276-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-006-0276-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:38Z","timestamp":1559145818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-006-0276-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":66,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["276"],"URL":"https:\/\/doi.org\/10.1007\/s10354-006-0276-7","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}